Fresh analysis indicates that people who discontinue new GLP-1 drugs like Wegovy and Mounjaro can put back on reduced body mass far faster than those who end traditional diet and exercise regimens.
Findings released in a prominent medical journal points out that while overweight individuals frequently drop about a fifth of their body weight while using the jabs, the weight returns at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals purchasing these drugs should be aware of the potential of rapid weight regain when the medication concludes," warns expert Dr. Susan Jebb.
This pace of recovery suggests a reversion to pre-treatment weight in about a year and a half.
Weighing Therapies
The analysis, which looked at 37 of studies involving thousands of participants, contrasted the outcomes of the injectable medications with older methods.
Scientists emphasize that individuals who lose weight through dieting typically see a slower creep back—perhaps 0.1 kg a month—after stopping.
The Reason for the Quick Rebound
Experts believe the way of the jabs explains the amplified regain.
GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Long-term administration of GLP-1 levels several times higher than the body's typical production could lead to the body to generate a reduced amount of its endogenous hormone, and may also reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Stopping of this medication means appetite is uncontrolled, making excessive eating much more probable."
An Ongoing Issue?
Medical guidelines recommend the jabs for individuals with weight-linked health risks, accompanied by recommended lifestyle changes.
A number of clinicians argue that, given the likelihood of relapse, the treatment should be considered life-long.
This perspective is reinforced by drug manufacturers, who state that the results "underscore the persistent character of excess weight," akin to managing conditions like hypertension.
Patient Accounts
Users who have discontinued the medication describe a intense return of cravings.
"It felt as if something flipping and I was suddenly ravenous," said a patient.
This challenge is worsened if users have not developed lasting lifestyle or habit modifications during treatment.
Significant Adoption
Figures suggest that a significant number of people in the UK have used weight-loss jabs in the past year, with interest continuing to grow.
- Use is higher among women compared to men.
- The middle-aged age group shows the greatest level of interest.
- A large proportion access the drugs through private healthcare rather than the NHS.
In conclusion, experts caution that while these medications are powerful tools for shedding pounds, they are not a magic cure and maintained weight loss relies on ongoing lifestyle changes.
